OLAPARIB DOSE REDUCTION IN PLATINUM-SENSITIVE OVARIAN CANCER RECURRENCE: REAL-WORLD DATA

被引:0
|
作者
Boccia, Serena Maria [1 ]
Culcasi, Camilla [1 ]
Sassu, Carolina Maria [1 ]
Guida, Fiorenza [1 ]
Apostol, Adriana Ionelia [1 ]
Vertechy, Laura [1 ]
Ferrandina, Gabriella [1 ,2 ]
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
Marchetti, Claudia [1 ,2 ]
机构
[1] IRCCS, Dipartimento Sci Salute Donna Bambino & Sanit Pu, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Sci Vita & Sanit Pubbl, Rome, Italy
关键词
D O I
10.1136/ijgc-2023-ESGO.668
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
887
引用
收藏
页码:A319 / A319
页数:1
相关论文
共 50 条
  • [1] Olaparib in Platinum-Sensitive Ovarian Cancer
    Kaji, Daisuke
    Miura, Yuji
    Takano, Toshimi
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 179 - 179
  • [2] THE REAL-WORLD EFFECT OF OLAPARIB IN BRCA-DEPENDENT PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER PATIENTS IN POLAND
    Blecharz, P.
    Madry, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A443 - A443
  • [3] Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer
    Moss, Haley A.
    Perhanidis, Jessica A.
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 50 - 56
  • [4] Platinum-sensitive ovarian cancer recurrence after PARP-inhibitor maintenance at first line: a real-world scenario
    Loverro, Matteo
    Marchetti, Claudia
    Capomacchia, Filippo Maria
    Caricato, Chiara
    Giannarelli, Diana
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A397 - A397
  • [5] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1382 - 1392
  • [6] Maintenance therapy utilization in platinum-sensitive recurrent epithelial ovarian cancer: A 'real-world' analysis
    Moss, H. A.
    Havrilesky, L. J.
    Kauff, N. D.
    Secord, A. A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 204 - 204
  • [7] Real-world data of olaparib maintenance therapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer: Final results of the C-PATROL study
    Marme, F.
    Hilpert, F.
    Welslau, M.
    Grabowski, J. P.
    Schneeweiss, A.
    Hartkopf, A. D.
    Becker, S.
    Runnebaum, I.
    Bauerschlag, D.
    Fasching, P.
    Brandi, C.
    Rehbein, J-K.
    Glowik, R.
    Sehouli, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S535 - S536
  • [8] Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
    Ledermann, Jonathan A.
    Pujade-Lauraine, Eric
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [9] Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer
    Vilming, Bente
    Fallas Dahl, Jorgen
    Bentzen, Anne Gry
    Ingebrigtsen, Vibeke Anett
    Berge Nilsen, Elisabeth
    Vistad, Ingvild
    Dorum, Anne
    Solheim, Olesya
    Bjorge, Line
    Zucknick, Manuela
    Aune, Guro
    Lindemann, Kristina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (12) : 1898 - 1905
  • [10] Overall survival in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer (PSROC) treated with olaparib maintenance: Real-world data of the C-PATROL study
    Marme, Frederik
    Hilpert, Felix
    Welslau, Manfred
    Grabowski, Jacek P.
    Schneeweiss, Andreas
    Hartkopf, Andreas D.
    Bauerschlag, Dirk
    Fasching, Peter A.
    Brandi, Christiane
    Rehbein, John-Kilian
    Glowik, Regina
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)